Переклад ще не готовий. Показано оригінал статті.
Healthcare stocks may struggle to gain momentum as Democrats prepare to take over Congress. Jared Holz, who covers healthcare for Mizuho, says the outlook for the sector is uncertain because of likely gridlock between lawmakers. "The next couple of years I really can't see too much happening," the firm's sector specialist told CNBC's " Fast Money " on Wednesday. "I'm not sure you want to own everything, but you can pick and choose the names… Pharma is trading more expensive than tech for the first time in 20 years. So, I backed away from pharma. I would look at medtech." The State Street Health Care Select ETF (XLV) jumped 3% a day after Election Day.
Головну думку ми показуємо публічно. Створіть безкоштовний акаунт, щоб читати повну статтю, зберігати її, обговорювати та поєднувати з ринковим і OSINT-контекстом.